Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastrointestinal Cancer
Metadata
Title
Different dosages of acetylsalicylic acid lead to adverse modifications of the reaction of rat pancreas to ethanol
Authors
Eva Siegmund
Ludwig Jonas
Ingitha Borisch
Utz Fechner
Uwe Käding
Heidrun Schröder
Publication date
01-04-1998
Publisher
Humana Press
Published in
Journal of Gastrointestinal Cancer / Issue 2/1998
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1385/IJGC:23:2:125

Other articles of this Issue 2/1998

Journal of Gastrointestinal Cancer 2/1998 Go to the issue

OriginalPaper

Sphincter of oddi manometry

State-Of-The-Art

The use of molecular technology in the differentiation of pancreatic cancer and chronic pancreatitis

OriginalPaper

Lexipafant fails to improve survival in severe necrotizing pancreatitis in rats

OriginalPaper

Near-infrared spectrometry analysis of fat, neutral sterols, bile acids, and short-chain fatty acids in the feces of patients with pancreatic maldigestion and malabsorption

OriginalPaper

Endoscopic ductal drainage may avoid resective surgery in painful chronic pancreatitis without large ductal dilatation

Case Report

Serous cystadenoma of the pancreas with atypical cells
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits